Roche Holding AG (OTCMKTS:RHHBY) Given Consensus Recommendation of “Hold” by Analysts

Shares of Roche Holding AG (OTCMKTS:RHHBY) have been given a consensus rating of “Hold” by the eleven research firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have given a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $51.50.

Several analysts recently weighed in on the stock. Morgan Stanley raised shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 price objective on the stock in a research note on Friday, April 24th. HSBC cut Roche from a “buy” rating to a “hold” rating in a research note on Monday, July 6th. Zacks Research cut Roche from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 14th. Finally, Argus upgraded shares of Roche from a “hold” rating to a “buy” rating in a research report on Monday, April 6th.

Institutional Investors Weigh In On Roche

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. McIlrath & Eck LLC purchased a new position in shares of Roche in the 1st quarter worth about $39,000. Oakworth Capital Inc. raised its position in Roche by 20.8% in the fourth quarter. Oakworth Capital Inc. now owns 1,658 shares of the company’s stock worth $86,000 after acquiring an additional 285 shares during the period. Atlas Capital Advisors Inc. bought a new stake in shares of Roche in the fourth quarter valued at $192,000. Pinnacle Wealth Management Advisory Group LLC bought a new stake in Roche in the 1st quarter valued at about $208,000. Finally, Enterprise Financial Services Corp boosted its position in Roche by 6.6% during the first quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock worth $277,000 after purchasing an additional 345 shares during the period.

Roche Stock Performance

Shares of OTCMKTS RHHBY opened at $55.08 on Thursday. The business’s 50 day moving average price is $51.82 and its two-hundred day moving average price is $52.82. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.38 and a quick ratio of 1.12. Roche has a twelve month low of $37.51 and a twelve month high of $60.85.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann?La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.